165 related articles for article (PubMed ID: 35968737)
1. Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions.
Dubé K; Agarwal H; Carter WB; Dee L; Taylor J; Roebuck C; Peterson B; Patel H; Ndukwe S; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Bateman K; Howell BJ; Azzoni L; Mounzer K; Tebas P; Montaner LJ
HIV Res Clin Pract; 2022 Aug; 23(1):76-90. PubMed ID: 35968737
[No Abstract] [Full Text] [Related]
2. Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United States.
Dubé K; Eskaf S; Hastie E; Agarwal H; Henley L; Roebuck C; Carter WB; Dee L; Taylor J; Mapp D; Campbell DM; Villa TJ; Peterson B; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Shipley L; Bateman K; Howell BJ; Mounzer K; Tebas P; Montaner LJ
J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207719
[TBL] [Abstract][Full Text] [Related]
3. "We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States.
Dubé K; Kanazawa J; Roebuck C; Johnson S; Carter WB; Dee L; Peterson B; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Shipley L; Bateman K; Howell BJ; Mounzer K; Tebas P; Montaner LJ
HIV Res Clin Pract; 2022 Dec; 23(1):120-135. PubMed ID: 35348047
[TBL] [Abstract][Full Text] [Related]
4. Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States.
Bilger A; Plenn E; Barg FK; Rendle KA; Carter WB; Lamour-Harrington A; Jones N; Peterson B; Sauceda JA; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dubé K
HIV Res Clin Pract; 2023 Oct; 24(1):2267825. PubMed ID: 37837376
[TBL] [Abstract][Full Text] [Related]
5. Perspectives on Analytical Treatment Interruptions in People Living with HIV and Their Health Care Providers in the Landscape of HIV Cure-Focused Studies.
Lau JSY; Smith MZ; Allan B; Martinez C; Power J; Lewin SR; McMahon JH
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):260-267. PubMed ID: 31608648
[TBL] [Abstract][Full Text] [Related]
6. Understanding participant perspectives around HIV-1 cure-related studies involving antiretroviral analytical treatment interruptions in the United Kingdom.
Lee MJ; Godakandaarachchi P; Collins S; Racz M; Sharp A; Fidler S; Fox J
J Virus Erad; 2023 Dec; 9(4):100360. PubMed ID: 38188642
[TBL] [Abstract][Full Text] [Related]
7. Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States.
Dubé K; Ndukwe SO; Korolkova A; Dee L; Sugarman J; Sauceda JA
HIV Res Clin Pract; 2024 Jan; 25(1):2312318. PubMed ID: 38348830
[TBL] [Abstract][Full Text] [Related]
8. "It comes altogether as one:" perceptions of analytical treatment interruptions and partner protections among racial, ethnic, sex and gender diverse HIV serodifferent couples in the United States.
Campbell DM; Dubé K; Cowlings PD; Dionicio P; Tam RM; Agarwal H; Stockman JK; Auerbach JD; Sauceda JA; Conroy AA; Johnson MO
BMC Public Health; 2022 Jul; 22(1):1317. PubMed ID: 35810288
[TBL] [Abstract][Full Text] [Related]
9. Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry.
Dubé K; Kanazawa J; Campbell C; Boone CA; Maragh-Bass AC; Campbell DM; Agosto-Rosario M; Stockman JK; Diallo DD; Poteat T; Johnson M; Saberi P; Sauceda JA
AIDS Res Hum Retroviruses; 2022 Jan; 38(1):50-63. PubMed ID: 33947268
[TBL] [Abstract][Full Text] [Related]
10. Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design.
Lau JSY; Cromer D; Pinkevych M; Lewin SR; Rasmussen TA; McMahon JH; Davenport MP
J Infect Dis; 2022 Aug; 226(2):236-245. PubMed ID: 35104873
[TBL] [Abstract][Full Text] [Related]
11. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research.
Dubé K; Kanazawa J; Dee L; Taylor J; Campbell DM; Brown B; Johnson MO; Saberi P; Sauceda JA; Sugarman J; Peluso MJ
HIV Res Clin Pract; 2021 Feb; 22(1):14-30. PubMed ID: 33757411
[No Abstract] [Full Text] [Related]
12. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting.
Julg B; Dee L; Ananworanich J; Barouch DH; Bar K; Caskey M; Colby DJ; Dawson L; Dong KL; Dubé K; Eron J; Frater J; Gandhi RT; Geleziunas R; Goulder P; Hanna GJ; Jefferys R; Johnston R; Kuritzkes D; Li JZ; Likhitwonnawut U; van Lunzen J; Martinez-Picado J; Miller V; Montaner LJ; Nixon DF; Palm D; Pantaleo G; Peay H; Persaud D; Salzwedel J; Salzwedel K; Schacker T; Sheikh V; Søgaard OS; Spudich S; Stephenson K; Sugarman J; Taylor J; Tebas P; Tiemessen CT; Tressler R; Weiss CD; Zheng L; Robb ML; Michael NL; Mellors JW; Deeks SG; Walker BD
Lancet HIV; 2019 Apr; 6(4):e259-e268. PubMed ID: 30885693
[TBL] [Abstract][Full Text] [Related]
13. Multiple treatment interruptions and protecting HIV-specific CD4 T cells enable durable CD8 T cell response and viral control.
Jain A; Canepa GE; Liou ML; Fledderman EL; Chapoval AI; Xiao L; Mukherjee I; Balogun BM; Huaman-Vergara H; Galvin JA; Kumar PN; Bordon J; Conant MA; Boyle JS
Front Med (Lausanne); 2024; 11():1342476. PubMed ID: 38808136
[TBL] [Abstract][Full Text] [Related]
14. Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA.
Strongin Z; Sharaf R; VanBelzen DJ; Jacobson JM; Connick E; Volberding P; Skiest DJ; Gandhi RT; Kuritzkes DR; O'Doherty U; Li JZ
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593048
[TBL] [Abstract][Full Text] [Related]
15. Analytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIV.
Papasavvas E; Lada SM; Joseph J; Yin X; Liu Q; Azzoni L; Mounzer K; Kostman JR; Richman D; Montaner LJ
AIDS; 2018 Aug; 32(13):1763-1772. PubMed ID: 30045057
[TBL] [Abstract][Full Text] [Related]
16. "I Know That I Was a Part of Making a Difference": Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption.
Neergaard R; Jones NL; Roebuck C; Rendle KA; Barbati Z; Peterson B; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dube K; Barg FK
AIDS Res Hum Retroviruses; 2023 Aug; 39(8):414-421. PubMed ID: 35979886
[TBL] [Abstract][Full Text] [Related]
17. Increasing the meaningful involvement of women in HIV cure-related research: a qualitative interview study in the United States.
Dubé K; Barr E; Philbin M; Perez-Brumer A; Minalga B; Peterson B; Averitt D; Picou B; Martel K; Chung C; Mejía M; Cameron M; Graham G; Dee L; Dixon Diallo D; Gordon E; Korolkova A; Dyer T; Auerbach JD; Scully E; Dong KL; Gianella S
HIV Res Clin Pract; 2023 Aug; 24(1):2246717. PubMed ID: 37608645
[TBL] [Abstract][Full Text] [Related]
18. Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment.
Henderson GE; Peay HL; Kroon E; Cadigan RJ; Meagher K; Jupimai T; Gilbertson A; Fisher J; Ormsby NQ; Chomchey N; Phanuphak N; Ananworanich J; Rennie S
J Med Ethics; 2018 Apr; 44(4):270-276. PubMed ID: 29127137
[TBL] [Abstract][Full Text] [Related]
19. "We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry.
Dubé K; Evans D; Dee L; Sylla L; Taylor J; Skinner A; Weiner BJ; Greene SB; Rennie S; Tucker JD
AIDS Res Hum Retroviruses; 2018 Jan; 34(1):67-79. PubMed ID: 28562069
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
